Acadia Healthcare Co (NASDAQ:ACHC) was upgraded by Zacks from a “neutral” rating to an “outperform” rating in a research report issued to clients and investors on Monday, Analyst Ratings Network.com reports. The firm currently has a $40.80 price objective on the stock. Zacks‘ price target suggests a potential upside of 7.09% from the stock’s previous close.
Shares of Acadia Healthcare Co (NASDAQ:ACHC) traded up 0.96% during mid-day trading on Monday, hitting $38.465. Acadia Healthcare Co has a 52 week low of $16.41 and a 52 week high of $38.18. The stock’s 50-day moving average is currently $34.61. The company has a market cap of $1.924 billion and a P/E ratio of 65.92.
Acadia Healthcare Co (NASDAQ:ACHC) last issued its quarterly earnings data on Tuesday, July 30th. The company reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.01. The company had revenue of $177.50 million for the quarter, compared to the consensus estimate of $169.21 million. Analysts expect that Acadia Healthcare Co will post $1.03 EPS for the current fiscal year.
Several other analysts have also recently commented on the stock. Analysts at RBC Capital raised their price target on shares of Acadia Healthcare Co from $35.00 to $39.00 in a research note to investors on Friday. They now have an “outperform” rating on the stock. Separately, analysts at Raymond James raised their price target on shares of Acadia Healthcare Co from $37.00 to $40.00 in a research note to investors on Friday. They now have an “outperform” rating on the stock. Finally, analysts at BMO Capital Markets raised their price target on shares of Acadia Healthcare Co from $35.00 to $40.00 in a research note to investors on Friday. They now have an “outperform” rating on the stock.
Nine research analysts have rated the stock with a buy rating, Acadia Healthcare Co has an average rating of “Buy” and an average target price of $36.48.
In other Acadia Healthcare Co news, major shareholder Karen Marie Prince sold 28,000 shares of Acadia Healthcare Co stock in a transaction dated Thursday, August 1st. The stock was sold at an average price of $35.80, for a total value of $1,002,400.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Major shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.
Acadia Healthcare Company, Inc is a provider of inpatient behavioral healthcare services in the United States.
To view Zacks’ full report, visit www.zacks.com
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.